Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | DHODH | Q02127 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | KIF11 | P52732 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CASP3 | P42574 | 1/20 | 0.40 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.40 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.40 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.40 |
| ▸ | RXRA | P19793 | 1/20 | 0.39 |
| ▸ | RXRB | P28702 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20741191 | 0.89 | MAPT (0.40) | MAPTKMT2ACYP2C9ALDH1A1ALOX15 | |
| SCHEMBL112703 | 0.89 | MAPT (0.55) | MAPTKMT2AALDH1A1ALOX15KIF11 | |
| SCHEMBL22323537 | 0.85 | RXRA (0.50) | MAPTKMT2AALDH1A1ALOX15DHODH | |
| SCHEMBL4070722 | 0.84 | CYP2C9 (0.48) | MAPTKMT2ACYP2C9ALDH1A1ALOX15 | |
| Propane SCHEMBL28558464 | 0.84 | MAPT (0.50) | MAPTKMT2AALDH1A1ALOX15SMN1; SMN2 | |
| SCHEMBL3290659 | 0.82 | CYP2C9 (0.47) | MAPTKMT2ACYP2C9ALDH1A1ALOX15 | |
| SCHEMBL13839048 | 0.82 | CYP2C9 (0.47) | MAPTKMT2ACYP2C9ALDH1A1ALOX15 | |
| SCHEMBL113257 | 0.81 | MAPT (0.46) | MAPTKMT2AALDH1A1ALOX15SMN1; SMN2 | |
| SCHEMBL155459 | 0.81 | MAPT (0.46) | MAPTKMT2AALDH1A1ALOX15SMN1; SMN2 | |
| SCHEMBL28649233 | 0.81 | PPARG (0.41) | ALDH1A1KIF11RXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3466 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12060334-B2 | 3-substituted phenazine derivatives as antimicrobial agents | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-08-13 | — | — | US | claimed |
| EP-3715346-B1 | THIAZOLYL-CONTAINING COMPOUNDS FOR TREATING PROLIFERATIVE DISEASES | DANA FARBER CANCER INST INC (US) | 2024-01-03 | — | — | EP | claimed |
| EP-2970107-B1 | PHOTOSWITCHABLE HDAC INHIBITORS | MASSACHUSETTS GEN HOSPITAL (US) | 2023-11-15 | — | — | EP | claimed |
| EP-3606528-B1 | TRICYCLIC COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 (GSK3) INHIBITORS AND USES THEREOF | BROAD INST INC (US) | 2023-10-18 | — | — | EP | claimed |
| EP-3291676-B1 | MITRAGYNINE ANALOGS AND USES THEREOF | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2022-08-17 | — | — | EP | claimed |
| US-11241435-B2 | Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis | THE GENERAL HOSPITAL CORPORATION (US) | 2022-02-08 | — | — | US | claimed |
| EP-3172213-B1 | MACROCYCLIC KINASE INHIBITORS AND USES THEREOF | DANA FARBER CANCER INST INC (US) | 2021-09-22 | — | — | EP | claimed |
| EP-3092220-B1 | VITAMIN C PRODRUGS AND USES THEREOF | UNIV FLORIDA (US) | 2021-01-20 | — | — | EP | claimed |
| US-10870651-B2 | Inhibitors of cyclin-dependent kinase 7 (CDK7) | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2020-12-22 | — | — | US | claimed |
| EP-3171874-B1 | IMIDAZOLYL KINASE INHIBITORS AND USES THEREOF | DANA FARBER CANCER INST INC (US) | 2020-11-18 | — | — | EP | claimed |
| JP-4830128-B2 | — | — | 2011-12-07 | — | — | JP | claimed |
| US-20070238895-A1 | N-protected aminoindanes and methods of their preparation | TEVA PHARMACEUTICALS USA, INC. | 2007-10-11 | — | — | US | claimed |
| WO-2007056455-A2 | N-PROTECTED AMINOINDANES AND METHODS OF THEIR PREPARATION | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2007-05-18 | — | — | WO | claimed |
| EP-1761554-A2 | PEPTIDE ANTIBIOTICS AND METHODS FOR MAKING SAME | Biosource Pharm, Inc. (US) | 2007-03-14 | — | — | EP | claimed |
| WO-2006083317-A2 | PEPTIDE ANTIBIOTICS AND METHODS FOR MAKING SAME | BIOSOURCE PHARM, INC. (US) | 2006-08-10 | — | — | WO | claimed |
| EP-1670809-A2 | SYNTHESIS AND MANUFACTURE OF PENTOSTATIN AND ITS PRECURSORS, ANALOGS AND DERIVATIVES | SuperGen, Inc. (US) | 2006-06-21 | — | — | EP | claimed |
| US-20050267056-A1 | Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives | MAYNE PHARMA (USA) INC. | 2005-12-01 | — | — | US | claimed |
| WO-2005027838-A2 | SYNTHESIS AND MANUFACTURE OF PENTOSTATIN AND ITS PRECURSORS, ANALOGS AND DERIVATIVES | SUPERGEN, INC. (US) | 2005-03-31 | — | — | WO | claimed |
| US-6103697-A | NOVEL HOMODIMERS THAT INCLUDE CYSTEINE-CONTAINING PEPTIDES HAVING 4-15 AMINO ACID RESIDUES | ASTRA AKTIEBOLAG (SE) | 2000-08-15 | — | — | US | claimed |
| US-5264583-A | Photographic coupler and method of making the same | EASTMAN KODAK COMPANY (US) | 1993-11-23 | — | — | US | claimed |